Literature DB >> 8119306

Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid sigma 1 system.

C C Chien1, G W Pasternak.   

Abstract

Both (+)-pentazocine and (-)-pentazocine antagonize morphine analgesia equally well. This lack of stereospecificity implies an non-opioid mechanism of action. The antagonism of morphine analgesia by (+)-pentazocine is reversed by haloperidol, a potent dopamine D2 and sigma receptor antagonist. The inactivity of the highly selective dopamine D2 receptor antagonist (-)-sulpiride indicates that both (+)-pentazocine and haloperidol are acting through sigma receptors. Haloperidol, but not (-)-sulpiride, also enhances morphine analgesia. Together, these results suggest the presence of a tonically active anti-opioid sigma system within the brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8119306     DOI: 10.1016/0014-2999(93)90650-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

Review 1.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

2.  Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studies.

Authors:  Montserrat Abadias; Marisol Escriche; Anna Vaqué; Mariano Sust; Gregorio Encina
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

Review 3.  The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.

Authors:  Tsung-Ping Su; Tzu-Chieh Su; Yoki Nakamura; Shang-Yi Tsai
Journal:  Trends Pharmacol Sci       Date:  2016-02-09       Impact factor: 14.819

4.  Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice.

Authors:  Miguel A Tejada; Angeles Montilla-García; Shane J Cronin; Domagoj Cikes; Cristina Sánchez-Fernández; Rafael González-Cano; M Carmen Ruiz-Cantero; Josef M Penninger; José M Vela; José M Baeyens; Enrique J Cobos
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

Review 5.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 6.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 7.  Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics.

Authors:  Michael Remesic; Victor J Hruby; Frank Porreca; Yeon Sun Lee
Journal:  ACS Chem Neurosci       Date:  2017-04-07       Impact factor: 4.418

8.  Effects of a selective sigma 1 antagonist compound on inflammatory pain.

Authors:  Carmela Parenti; Agostino Marrazzo; Giuseppina Aricò; Giuseppina Cantarella; Orazio Prezzavento; Simone Ronsisvalle; Giovanna Maria Scoto; Giuseppe Ronsisvalle
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

9.  Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding.

Authors:  Felix J Kim; Ivanka Kovalyshyn; Maxim Burgman; Claire Neilan; Chih-Cheng Chien; Gavril W Pasternak
Journal:  Mol Pharmacol       Date:  2010-01-20       Impact factor: 4.436

10.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.